BioSpace News Archive

Combined Company Will Grow Shareholder Value and Transform Healthcare In an Increasingly Demanding Healthcare Environment

The ARM Foundation for Cell and Gene Medicine (ARM Foundation) today released its first-of-its-kind Health Economic Impact Landscape Analysis of regenerative medicine advanced therapy.

Ipsidy Inc. announced its results for the quarter ended June 30, 2018 and that it has received subscriptions for common stock in an equity fund raising of approximately $9.6 million.

Sienna Cancer Diagnostics Ltd, (ASX:SDX) (“Sienna” or “the Company”), a medical technology company developing and commercialising innovative cancer related tests, is pleased to announce it has appointed Shaanxi GaoYuan In Vitro Diagnostic Reagents Co. (“GaoYuan”) as the Company’s exclusive distribution partner for mainland China.

Canopy Growth Corporation will release its financial results for the first quarter ended June 30, 2018 on August 14, 2018 after financial markets close.

Tilray Inc. announced it will report results for the second quarter ended June 30, 2018 on Tuesday, August 28, 2018 after market close.

Johnson & Johnson will participate in the 2018 Wells Fargo 13th Annual Healthcare Conference on Thursday, Sept. 6th, at The Westin Boston Waterfront in Boston, MA.

United Therapeutics Corporation announced today that James Edgemond, Chief Financial Officer and Treasurer of United Therapeutics, will provide an overview and update on the company’s business at the 2018 Wedbush PacGrow Healthcare Conference in New York City.

Evolent is providing its Identifi platform and Risk Adjustment solution to enhance risk adjustment performance and support 500 providers in the Los Angeles metro area

Dr. Samuel Agresta Appointed as Chief Medical Officer